Abstract The prevalence of learning disabilities (LD) among children is a critical public health issue; however, recent LD prevalence estimates among children and adolescents aged 6–17 years, as reported by the National Survey of Children’s Health (NSCH), remain largely unexplored. Data for this population-based cross-sectional study were obtained from NSCH to estimate the prevalence of LD diagnosis among U.S. children at both national and state levels, and to inspect the 7-year trends in these estimates from 2016 to 2022. Among 187,805 U.S. children, 17,379 had a history of LD diagnosis, with a weighted prevalence of 8.80% (95% CI = 8.52–9.08). Of these, 16,221 were currently diagnosed with LD, yielding a weighted prevalence of 8.20% (95% CI = 7.93–8.48). From 2016 to 2022, the prevalence of ever-diagnosed LD increased from 7.86–9.45%, and that of current-diagnosed LD from 7.32–8.80%, indicating a 20% total increase in both types. The state with the highest prevalence (New Hampshire) had twice that of the state with the lowest prevalence (Utah). This study highlights a critical escalation in LD prevalence among US children and adolescents between 2016 and 2022. Comprehensive screening and support programs must be implemented to enhance early identification and intervention.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: